Agile Therapeutics to be acquired by Spain-based Insud for an enterprise value of ~$45M
2024-06-26
cagkansayin Agile Therapeutics (OTC:AGRX) said on Wednesday that the Spain-based pharmaceutical group Insud Pharma is set to acquire the women’s healthcare company, valuing AGRX at an enterprise value of ~$45M. Insud’s U.S. subsidiary, Exeltis Project, will merge with Agile as part of the transaction. The transaction is priced at $1.52Continue Reading